Wafik El-Deiry: Striving for impact on our community and region
Wafik El-Deiry shared a post on LinkedIn:
“Thankful to our Legorreta Cancer Center administration and leaders for all the hard work of preparation and presentations to our EAB today. Also grateful for all the feedback we received from our advisors. Our work is intensifying as we strive for impact on our community and region.”
Source: Wafik El-Deiry/LinkedIn
More posts featuring Wafik El-Deiry on oncodaily.com
Wafik S. El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals.
He is the Editor in Chief at Oncotarget. Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023